Short-course of oral miltefosine for treatment of visceral leishmaniasis

Clinical Infectious Diseases

Volumn 31, Issue 4, 2000, Pages 1110-1113

  Sundar, Shyam ^a   Makharia, Anand ^a   More, Deepak K ^a   Agrawal, Gaurav ^a   Voss, Andreas ^b   Fischer, Christina ^b   Bachmann, Peter ^b   Murray, Henry W ^c  

^a BANARAS HINDU UNIVERSITY   (India)

^b ASTA MEDICA AG   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MILTEFOSINE;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SHORT COURSE THERAPY; SIDE EFFECT; VISCERAL LEISHMANIASIS;

ADMINISTRATION, ORAL; ADULT; ANTIPROTOZOAL AGENTS; DIARRHEA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEISHMANIASIS, VISCERAL; MALE; PHOSPHORYLCHOLINE; VOMITING;

EID: 0034450717     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318122     Document Type: Article

References (12)

1. Trial of oral miltefosine for visceral leishmaniasis
2. Oral treatment of visceral leishmaniasis with miltefosine
3. Efficacy and toxicity of miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis
4. Phase I study of weekly oral miltefosine (hexadecylphosphocholine) in cancer patients
5. A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic tumours
6. Meaningful clinical classification of therapeutic response to anti-cancer drugs
7. Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony
8. Kala-azar (visceral leishmaniasis) control
9. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases
10. Randomised controlled trial of aminosidine (paromomycin) v. Sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India
11. Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic